benign prostatic hyperplasia lower urinary tract symptoms nonalcoholic fatty liver disease prostate cancer prostatic diseases

Anticoagulant therapy benign Prostatic Hyperplasia

benign prostatic hyperplasia dutasteride finasteride meta-analysis randomized controlled trials

Benign Prostatic Hyperplasia Tamsulosin PDE5-Is Lower Urinary Tract Symptoms Lower Urinary Tract Symptoms

Aged Humans Lasers Solid-State Male Middle Aged Postoperative Complications/etiology Prostatic Hyperplasia Quality of Life Transurethral Resection of Prostate Treatment Outcome Volatilization Greenlight photoselective vaporization Holmium laser technologies Laser therapy Meta-analysis Prostate Prostatic hyperplasia

Anticoagulants Humans Male Platelet Aggregation Inhibitors Postoperative Hemorrhage/chemically induced Prostatic Hyperplasia *Transurethral Resection of Prostate

Lasers bipolar technology benign prostatic enlargement systematic review meta-analysis

Aged Drug Therapy Combination Erectile Dysfunction/*drug therapy Humans Male Middle Aged Phosphodiesterase Inhibitors Prostatic Hyperplasia/*drug therapy Tadalafil Tamsulosin Treatment Outcome Vasodilator Agents *benign prostatic hyperplasia *erectile dysfunction *meta-analysis *tadalafil *tamsulosin conflicts of interest with respect to the research authorship and/or publication of this article.

5-alpha Reductase Inhibitors/*administration & dosage Adrenergic alpha-1 Receptor Antagonists/*administration & dosage Drug Therapy Combination Dutasteride/*administration & dosage Erectile Dysfunction/chemically induced/diagnosis Humans Male Prostatic Hyperplasia/diagnosis/*drug therapy/epidemiology Randomized Controlled Trials as Topic/methods Tamsulosin/*administration & dosage Treatment Outcome Benign prostatic hyperplasia Dutasteride Meta-analysis Randomized controlled trials Tamsulosin published studies thus no ethical approval and patient consent are required. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Phosphodiesterase type 5 inhibitor Lower urinary tract symptoms Benign prostatic hyperplasia Meta-analysis

Statins Benign prostatic hyperplasia Lower urinary tract symptoms Meta-analysis

Benign prostate hyperplasia metabolic syndrome meta-analysis

Thulium laser vaporesection of prostate bipolar transurethral resection of prostate benign prostate hyperplasia meta-analysis

Transurethral enucleation of the prostate transvesical open prostatectomy benign prostatic hyperplasia meta-analysis

Aged Humans Male Middle Aged Prostatic Hyperplasia/blood Prostatic Neoplasms/*blood Publication Bias Sensitivity and Specificity Zinc/*blood

Humans *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/pathology *Urologic Neoplasms/drug therapy/pathology Antibodies Monoclonal/adverse effects

Male Humans *Papillomavirus Infections/complications/epidemiology/prevention & control Human Papillomavirus Viruses Mendelian Randomization Analysis Papillomaviridae/genetics Human papillomavirus 18 *Urinary Bladder Neoplasms/epidemiology/complications HPV prevalence bladder cancer human papillomavirus mendelian randomization meta-analysis

Biomarkers/urine Carcinogenesis Carcinogens/toxicity Female Humans Male *Tobacco Products/adverse effects *Urinary Bladder Neoplasms/etiology Biomarkers of exposure Bladder cancer Carcinogens Heated tobacco product Urine disclosures.

*Carcinoma Transitional Cell Humans Prognosis Retrospective Studies *Urinary Bladder Neoplasms/surgery *Urinary Tract